K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with the U. S.
Search results for "Phase 3 trial"
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is expected to heat up even...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
New Discovery of Diabetes Drug Metformin: Long COVID Symptoms May Disappear
Among people infected with COVID-19, about 1 in 4 report experiencing symptoms of Long COVID, such as fatigue, brain...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
"Oh, Is It Better Than Medicine?": Just Two Days of Eating Oatmeal Reduces Bad Cholesterol by 10%
Research results have shown that maintaining an oat-based diet for a short period can significantly lower bad...
BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents
The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for...
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA
HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...